Corilagin prevents non-alcoholic fatty liver disease via improving lipid metabolism and glucose homeostasis in high fat diet-fed mice

Non-alcoholic fatty liver disease (NAFLD) has been considered to be one of the most common chronic liver diseases. However, no validated pharmacological therapies have been officially proved in clinic due to its complex pathogenesis. The purpose of this study was to examine the protective effects of...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Mingjuan, Zhang, Rong, Wang, Yongling, Mao, Ziming, Wu, Jing, Guo, Huaqi, Zhang, Kaiwen, Jing, Yu, Zhang, Caoxu, Song, Huaidong, Chen, Xia, Wei, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Nutrition
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9443665/
https://www.ncbi.nlm.nih.gov/pubmed/36071929
http://dx.doi.org/10.3389/fnut.2022.983450

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9443665/
https://www.ncbi.nlm.nih.gov/pubmed/36071929
http://dx.doi.org/10.3389/fnut.2022.983450

Ejemplares similares